相关实验视频

Updated: Jun 7, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

IL1RN VNTR和NKG2A多态与肝炎E感染的关联,来自印度西部的案例研究

Anuradha S Tripathy¹, Priyanka Wagh², Gajendra Shahapure²

¹ICMR-National Institute of Virology, Pune, Maharashtra, India. anuradhastripathy@hotmail.com.

Archives of virology

|November 19, 2024

概括

干白素1受体对抗剂 (IL1RN) 和NKG2A的遗传变异会影响E型肝炎病毒 (HEV) 感染的易感性. 某些IL1RN和NKG2A多态性提供对HEV的保护,而其他可能会增加风险.

科学领域:

免疫遗传学免疫遗传学
病毒学病毒学
人类遗传学人类遗传学

背景情况:

自然杀手 (NK) 细胞对于抗病毒免疫至关重要,它们的功能通过激活和抑制受体进行调节.
介质素1受体对抗剂 (IL1RN) 作为介质素1 (IL-1) 的竞争性抑制剂.
免疫反应基因的遗传变异可能会影响对肝炎E病毒 (HEV) 等病毒感染的易感性.

研究的目的:

研究IL1RN和NKG2A基因中的遗传多态性之间的关联以及它们在E型肝炎病毒 (HEV) 感染中的作用.
确定IL1RN和NKG2A中的特定单核酸多态 (SNP) 是否与对HEV感染的保护或易感性有关.

主要方法:

使用了聚合酶链反应限制片段长度多态性 (PCR-RFLP) 试验.
该研究包括111名HEV感染的患者和222名HEV无感染的健康对照.
基因型定型侧重于IL1RN和NKG2A基因内的内基单核酸多态 (SNP).

主要成果:

在IL1RN (VNTR) 基因中的SNP,特别是2等位基因,显示出与对HEV感染的保护有显著的关联 (OR = 0.26,p < 0.001).
在NKG2A的内基区域中的多态性显示了共同主导模型中的保护性关联 (例如,A/A与G/G,OR=0.25,p<0.05).
同样的NKG2A多态性与主导 (OR = 2.28,p < 0.05) 和衰退 (OR = 2.71,p < 0.001) 模型中的敏感性增加有关.

结论:

在IL1RN和NKG2A的遗传多态性在宿主对HEV感染的反应中起着重要作用.
这些遗传变异可以对HEV感染产生保护性和有害的影响.
需要进一步的研究来阐明这些多形态对HEV疾病结果的确切影响.

关键词:

肝炎E感染的感染.在 IL1RN 中, IL1RN 是在NKG2A中,NKG2A是NKG2A.多态性多态性多态性西印度人人口西印度人人口

更多相关视频

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes

Published on: March 6, 2019

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...